Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation Therapy for Locoregionally Advanced Head and Neck Cancer: HPV-negative Subset Analysis
2016 ◽
Vol 94
(4)
◽
pp. 867
Keyword(s):
Phase 2
◽
2020 ◽
Vol 106
(2)
◽
pp. 320-328
◽
2012 ◽
Vol 84
(3)
◽
pp. S523